Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the results of recent studies of approved and investigational antiretroviral agents.
- Discuss recent insights into the management and prevention of metabolic complications and lipodystrophy in HIV-infected patients.
- Review new findings on the epidemiology and management of antiretroviral-induced hepatotoxicity and hepatitis coinfection in HIV-infected patients.
Review and download slides summarizing the most clinically relevant data on antiretroviral therapy and complications of HIV disease at the recent Dublin meetings.
This slide presentation is in Microsoft PowerPoint format and is available for download within the CME module.
Topics covered include:
-
Metabolic Effects of HIV Infection and Antiretroviral Therapy
-
Antiretroviral Strategies for Improving Dyslipidemia and Lipoatrophy
-
Novel Treatments for Dyslipidemia and Lipoatrophy in HIV-Infected Patients
-
New Data on Current and Investigational Antiretroviral Agents
-
New Data on Drug Resistance and Pharmacology
-
New Insights on Hepatotoxicity and Managing Hepatitis-Coinfected Patients